Translating Animal Studies

High doses of nicotinamide riboside and nicotinamide mononucleotide used in animal studies raise questions about their applicability to humans. While some doses appear manageable, concerns about bioavailability and the metabolic pathways involved in NAD production are crucial for understanding their potential effects. The distinction between direct NAD formation and the salvage pathway could significantly impact how these compounds function in human physiology.